カテゴリー： QYResearch, 世界

世界のT細胞特異的表面糖タンパク質CD28市場 2019年

【英語タイトル】Global T Cell Specific Surface Glycoprotein CD28 Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16233）・商品コード：DATA909X16233
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、T細胞特異的表面糖タンパク質CD28の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FPT-155、FR-104、ルリズマブペゴル、その他に、用途別には、プラーク乾癬、固形腫瘍、急性腎不全（ARF）、その他にセグメント区分し、T細胞特異的表面糖タンパク質CD28の世界市場を分析しました。


・エグゼクティブ・サマリー
・T細胞特異的表面糖タンパク質CD28の世界市場概要
・T細胞特異的表面糖タンパク質CD28の製造コスト構成分析
・T細胞特異的表面糖タンパク質CD28の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・T細胞特異的表面糖タンパク質CD28の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・T細胞特異的表面糖タンパク質CD28のセグメント分析（種類別）
（FPT-155、FR-104、ルリズマブペゴル、その他）
・T細胞特異的表面糖タンパク質CD28のセグメント分析（用途別）
（プラーク乾癬、固形腫瘍、急性腎不全（ARF）、その他）
・T細胞特異的表面糖タンパク質CD28の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Atox Bio Ltd、Bristol-Myers Squibb Co、Five Prime Therapeutics Inc、Johnson & Johnson、TheraMAB LLC、）
・T細胞特異的表面糖タンパク質CD28の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global T Cell Specific Surface Glycoprotein CD28 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on T Cell Specific Surface Glycoprotein CD28 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Specific Surface Glycoprotein CD28 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Specific Surface Glycoprotein CD28 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their T Cell Specific Surface Glycoprotein CD28 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Atox Bio Ltd
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
Johnson & Johnson
TheraMAB LLC
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
FPT-155
FR-104
Lulizumab Pegol
Others

Segment by Application
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of T Cell Specific Surface Glycoprotein CD28
1.1 Definition of T Cell Specific Surface Glycoprotein CD28
1.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type
1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 FPT-155
1.2.3 FR-104
1.2.4 Lulizumab Pegol
1.2.5 Others
1.3 T Cell Specific Surface Glycoprotein CD28 Segment by Applications
1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption Comparison by Applications (2014-2025)
1.3.2 Plaque Psoriasis
1.3.3 Solid Tumor
1.3.4 Acute Renal Failure(ARF)
1.3.5 Others
1.4 Global T Cell Specific Surface Glycoprotein CD28 Overall Market
1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue (2014-2025)
1.4.2 Global T Cell Specific Surface Glycoprotein CD28 Production (2014-2025)
1.4.3 North America T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
1.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
1.4.5 China T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
1.4.6 Japan T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
1.4.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
1.4.8 India T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28
2.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
2.4 Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28

3 Development and Manufacturing Plants Analysis of T Cell Specific Surface Glycoprotein CD28
3.1 Capacity and Commercial Production Date
3.2 Global T Cell Specific Surface Glycoprotein CD28 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of T Cell Specific Surface Glycoprotein CD28
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 T Cell Specific Surface Glycoprotein CD28 Production and Capacity Analysis
4.2 T Cell Specific Surface Glycoprotein CD28 Revenue Analysis
4.3 T Cell Specific Surface Glycoprotein CD28 Price Analysis
4.4 Market Concentration Degree

5 T Cell Specific Surface Glycoprotein CD28 Regional Market Analysis
5.1 T Cell Specific Surface Glycoprotein CD28 Production by Regions
5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Regions
5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions
5.2 T Cell Specific Surface Glycoprotein CD28 Consumption by Regions
5.3 North America T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.3.1 North America T Cell Specific Surface Glycoprotein CD28 Production
5.3.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America T Cell Specific Surface Glycoprotein CD28 Import and Export
5.4 Europe T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.4.1 Europe T Cell Specific Surface Glycoprotein CD28 Production
5.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Import and Export
5.5 China T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.5.1 China T Cell Specific Surface Glycoprotein CD28 Production
5.5.2 China T Cell Specific Surface Glycoprotein CD28 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China T Cell Specific Surface Glycoprotein CD28 Import and Export
5.6 Japan T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.6.1 Japan T Cell Specific Surface Glycoprotein CD28 Production
5.6.2 Japan T Cell Specific Surface Glycoprotein CD28 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan T Cell Specific Surface Glycoprotein CD28 Import and Export
5.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.7.1 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production
5.7.2 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Import and Export
5.8 India T Cell Specific Surface Glycoprotein CD28 Market Analysis
5.8.1 India T Cell Specific Surface Glycoprotein CD28 Production
5.8.2 India T Cell Specific Surface Glycoprotein CD28 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India T Cell Specific Surface Glycoprotein CD28 Import and Export

6 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Type)
6.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Type
6.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type
6.3 T Cell Specific Surface Glycoprotein CD28 Price by Type

7 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Application)
7.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption by Application
7.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption Market Share by Application (2014-2019)

8 T Cell Specific Surface Glycoprotein CD28 Major Manufacturers Analysis
8.1 Atox Bio Ltd
8.1.1 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
8.1.2 Atox Bio Ltd Product Introduction, Application and Specification
8.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Co
8.2.1 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Five Prime Therapeutics Inc
8.3.1 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
8.3.2 Five Prime Therapeutics Inc Product Introduction, Application and Specification
8.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
8.4.2 Johnson & Johnson Product Introduction, Application and Specification
8.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 TheraMAB LLC
8.5.1 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
8.5.2 TheraMAB LLC Product Introduction, Application and Specification
8.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of T Cell Specific Surface Glycoprotein CD28 Market
9.1 Global T Cell Specific Surface Glycoprotein CD28 Market Trend Analysis
9.1.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Volume and Value) Forecast 2019-2025
9.2 T Cell Specific Surface Glycoprotein CD28 Regional Market Trend
9.2.1 North America T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.2.3 China T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.2.4 Japan T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.2.5 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.2.6 India T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
9.3 T Cell Specific Surface Glycoprotein CD28 Market Trend (Product Type)
9.4 T Cell Specific Surface Glycoprotein CD28 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 T Cell Specific Surface Glycoprotein CD28 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of T Cell Specific Surface Glycoprotein CD28
Table Global T Cell Specific Surface Glycoprotein CD28 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global T Cell Specific Surface Glycoprotein CD28 Production Market Share by Types in 2018
Figure FPT-155 Product Picture
Figure FR-104 Product Picture
Figure Lulizumab Pegol Product Picture
Figure Others Product Picture
Table Global T Cell Specific Surface Glycoprotein CD28 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global T Cell Specific Surface Glycoprotein CD28 Consumption Market Share by Applications in 2018
Figure Plaque Psoriasis
Figure Solid Tumor
Figure Acute Renal Failure(ARF)
Figure Others
Figure Global T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) (2014-2025)
Figure Global T Cell Specific Surface Glycoprotein CD28 Production (K Pcs) (2014-2025)
Figure North America T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Figure Europe T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Figure China T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Figure Japan T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Figure Southeast Asia T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Figure India T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) (2014-2025)
Table T Cell Specific Surface Glycoprotein CD28 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28 in 2018
Figure Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
Figure Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global T Cell Specific Surface Glycoprotein CD28 Manufacturing Plants Distribution
Table T Cell Specific Surface Glycoprotein CD28 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table T Cell Specific Surface Glycoprotein CD28 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table T Cell Specific Surface Glycoprotein CD28 Production (K Pcs) of Major Manufacturers (2014-2019)
Table T Cell Specific Surface Glycoprotein CD28 Production Market Share of Major Manufacturers (2014-2019)
Figure T Cell Specific Surface Glycoprotein CD28 Production Share by Manufacturers in 2018
Table T Cell Specific Surface Glycoprotein CD28 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table T Cell Specific Surface Glycoprotein CD28 Revenue Market Share of Major Manufacturers (2014-2019)
Figure T Cell Specific Surface Glycoprotein CD28 Revenue Share by Manufacturers in 2018
Table T Cell Specific Surface Glycoprotein CD28 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global T Cell Specific Surface Glycoprotein CD28 Production by Regions 2014-2019 (K Pcs)
Table Global T Cell Specific Surface Glycoprotein CD28 Production Market Share by Regions 2014-2019
Figure Global T Cell Specific Surface Glycoprotein CD28 Production Market Share by Regions in 2018
Table Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions 2014-2019 (Million USD)
Table Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions 2014-2019
Figure Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Regions in 2018
Table Global T Cell Specific Surface Glycoprotein CD28 Consumption by Regions 2014-2019 (K Pcs)
Table Global T Cell Specific Surface Glycoprotein CD28 Consumption Market Share by Regions 2014-2019
Figure North America T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure North America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table North America T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure Europe T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure China T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure China T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table China T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure Japan T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure India T Cell Specific Surface Glycoprotein CD28 Production Growth Rate 2014-2019 (K Pcs)
Figure India T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate 2014-2019 (Million USD)
Table India T Cell Specific Surface Glycoprotein CD28 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption T Cell Specific Surface Glycoprotein CD28 Market Share by Application (2014-2019)
Figure Global Value (Consumption) T Cell Specific Surface Glycoprotein CD28 Market Share by Application (2014-2019)
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product Introduction, Application and Specification
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Growth Rate (2014-2019)
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Market Share (2014-2019)
Figure Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Revenue Market Share (2014-2019)
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Main Business and Markets Served
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Main Business and Markets Served
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product Introduction, Application and Specification
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Growth Rate (2014-2019)
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Market Share (2014-2019)
Figure Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Revenue Market Share (2014-2019)
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Main Business and Markets Served
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product Introduction, Application and Specification
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Growth Rate (2014-2019)
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Market Share (2014-2019)
Figure Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Revenue Market Share (2014-2019)
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Main Business and Markets Served
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product Introduction, Application and Specification
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Growth Rate (2014-2019)
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Market Share (2014-2019)
Figure TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share (2014-2019)
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Main Business and Markets Served
Figure Global T Cell Specific Surface Glycoprotein CD28 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global T Cell Specific Surface Glycoprotein CD28 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India T Cell Specific Surface Glycoprotein CD28 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of T Cell Specific Surface Glycoprotein CD28 by Type (2019-2025)
Table Global Consumption (K Pcs) of T Cell Specific Surface Glycoprotein CD28 by Application (2019-2025)
Table T Cell Specific Surface Glycoprotein CD28 Distributors List
Table T Cell Specific Surface Glycoprotein CD28 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Atox Bio Ltd、Bristol-Myers Squibb Co、Five Prime Therapeutics Inc、Johnson & Johnson、TheraMAB LLC、

★調査レポート[世界のT細胞特異的表面糖タンパク質CD28市場 2019年] (コード：DATA909X16233)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のT細胞特異的表面糖タンパク質CD28市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のT細胞表面糖タンパク質CD4市場 2019年
    DATA909X16234 / QYResearch / 2019年11月20日 / ※本調査レポートは、T細胞表面糖タンパク質CD4の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他に、用途別には、HIV、エイズ、GVHD、SARS、その他にセグメント区分し、T細胞表面糖タンパク質CD4の世界市場を分析しました。 ・エグゼクティブ・サマリー ・T細胞表面糖タンパク質CD4の世界市場概要 ・T細胞表面糖タンパク質CD4の製造コスト構成分析 ・T細胞表面糖タンパク質CD4の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・T細胞表面糖タンパク質CD4の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・T細胞表面糖タンパク質CD4のセグメント分析（種類別） （酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他）...The global T Cell Surface Glycoprotein CD4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Surface Glycoprotein CD4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Surface Glycoprotein CD4 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Surface Glycoprotein CD4 in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の細胞表面マーカー市場 2019年
    DATA909X05257 / QYResearch / 2019年11月15日 / ※本調査レポートは、細胞表面マーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヒト細胞表面マーカー、マウス細胞表面マーカー、ラット細胞表面マーカー、その他に、用途別には、研究、医療用にセグメント区分し、細胞表面マーカーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・細胞表面マーカーの世界市場概要 ・細胞表面マーカーの製造コスト構成分析 ・細胞表面マーカーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・細胞表面マーカーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・細胞表面マーカーのセグメント分析（種類別） （ヒト細胞表面マーカー、マウス細胞表面マーカー、ラット細胞表面マーカー、その他）...The global Cell Surface Markers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cell Surface Markers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cell Surface Markers market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cell Surface Markers in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヒトサイトメガロウイルスエンベロープ糖タンパク質B市場 2019年
    DATA909X09338 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他に、用途別には、感染症、腫瘍学、女性の健康、その他にセグメント区分し、ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの世界市場概要 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの製造コスト構成分析 ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒトサイトメガロウイルスエンベロープ糖タンパク質Bのセグメント分析（種類別） （CSJ-148、CyMVectin、TRL-345、PPCM、サイトメガロウイルスワクチン、その他）...The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Human Cytomegalovirus Envelope Glycoprotein B volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Cytomegalovirus Envelope Glycoprotein B market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Human Cytomegalovirus Envelope Glycoprotein B in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の特定用途向けIC(ASIC)市場 2019年
    DATA909X03692 / QYResearch / 2019年11月15日 / ※本調査レポートは、特定用途向けIC(ASIC)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フルカスタム設計、スタンダードセルベース、ゲートアレイベースに、用途別には、AR＆VRデバイス、自動車、家電、その他にセグメント区分し、特定用途向けIC(ASIC)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・特定用途向けIC(ASIC)の世界市場概要 ・特定用途向けIC(ASIC)の製造コスト構成分析 ・特定用途向けIC(ASIC)の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・特定用途向けIC(ASIC)の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・特定用途向けIC(ASIC)のセグメント分析（種類別） （フルカスタム設計、スタンダードセルベース、ゲートアレイベース）...The global Application Specific IC (ASIC) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Application Specific IC (ASIC) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Application Specific IC (ASIC) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Application Specific IC (ASIC) in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の前立腺特異抗原市場 2019年
    DATA909X13816 / QYResearch / 2019年11月20日 / ※本調査レポートは、前立腺特異抗原の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、G-115、INO-5150、ADXS-PSA、AEZS-120、その他に、用途別には、前立腺がん、転移ホルモン抵抗性前立腺がん、その他にセグメント区分し、前立腺特異抗原の世界市場を分析しました。 ・エグゼクティブ・サマリー ・前立腺特異抗原の世界市場概要 ・前立腺特異抗原の製造コスト構成分析 ・前立腺特異抗原の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・前立腺特異抗原の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・前立腺特異抗原のセグメント分析（種類別） （G-115、INO-5150、ADXS-PSA、AEZS-120、その他）...The global Prostate Specific Antigen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prostate Specific Antigen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Specific Antigen market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prostate Specific Antigen in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆